BridgeMD

Sign in

Treatment clinical trials

Explore recruiting treatment clinical trials.

Recruiting treatment studies right now

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Treatment trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Evaluation of the efficacy and safety of empagliflozin in the treatment of neutropenia in patients with glycogenosis Ib. EMPAtia.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

Glaucoma Intensity Treatment Study – Intensive non-invasive glaucoma treatment vs conventional stepwise treatment – a prospective, randomized phase IV study of disease progression in glaucoma

Sweden

Therapeutic use (Phase IV) EU CTIS Study details

Open-label, double-arm, controlled, randomized, multicentre clinical trial to evaluate the impact of pharmacogenetic-guided treatment in patients with insufficiently controlled type 2 diabetes

Spain

Therapeutic use (Phase IV) EU CTIS Study details

INNOVATIVE TREATMENT OF SCARRED VOCAL FOLDS BY LOCAL INJECTION OF AUTOLOGOUS ADIPOSE-DERIVED STROMAL VASCULAR FRACTION: EFFICACY VERSUS PLACEBO

France

Therapeutic exploratory (Phase II) EU CTIS Study details

AMIND - AMIloride for the treatment of Nephrogenic Diabetes insipidus for patients with bipolar disorder treated with lithium: a randomized controlled trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

THERIPEX - A phase I/II open label non-randomized study, monocentric, single-arm, evaluating Safety and Efficacy of induced T-CD4 Treg by LV vector transduction expressing the FoxP3 cDNA in patients with IPEX syndrom

France

Human Pharmacology (Phase I)- First administration to humans EU CTIS Study details

Treatment trials by city

Treatment in Toronto Treatment in Vancouver Treatment in Montreal Treatment in Calgary Treatment in Edmonton Treatment in Ottawa Treatment in Winnipeg Treatment in Quebec City Treatment in Hamilton Treatment in Kitchener Treatment in London Treatment in Halifax Treatment in New York Treatment in Los Angeles Treatment in Chicago Treatment in Houston